A breakthrough in cancer treatment research has been achieved by a team of researchers at Bar-Ilan University with the development of new immune system technology. This innovative biotech aims to customize cancer patients’ treatments based on their individual immune system responses.
The new technology focuses on monitoring changes in immune system cells surrounding cancer cells, providing insights into how the patient’s body is reacting to immunotherapy. Immunotherapy is a specialized treatment approach that stimulates the immune system to target and eliminate cancer cells.
For the first time, scientists have successfully measured the interaction between immune cells and cancer cells directly from a patient’s biopsy. The research, led by Dr. Shahar Alon from Bar-Ilan’s Faculty of Engineering in collaboration with the Israel Cancer Association, observed the behavior of immune cells in close proximity to cancerous tissue.
Notably, specific types of immune cells exhibit distinct genetic signatures when near cancer cells, indicating a unique response pattern. This observation can provide valuable insights for healthcare providers in making informed decisions regarding individualized immunotherapy treatments.
Dr. Alon emphasized the significance of understanding how cancer cells influence immune cell behavior, stating that this knowledge enhances the comprehension of the complex dynamics between the two cell types. The research findings hold promise for advancing cancer treatment strategies and improving patient outcomes.
Moshe Bar Haim, CEO of the Israel Cancer Association, highlighted the global impact of such breakthroughs, emphasizing the potential benefits for patients worldwide. By unraveling the immune system’s response to cancer cells, researchers aim to enhance treatment efficacy and increase recovery rates.
The study detailing these groundbreaking findings was recently published in the RNA scientific journal, marking a significant milestone in cancer research. This development underscores the importance of continuous innovation in the medical field to address complex diseases like cancer.
Stay updated with the latest news and innovations by subscribing to NoCamels’ weekly newsletter for top stories in technology, science, and more.
